Business Context and Reporting Period
Company: Diageo plc
Filing Type: Form 6-K (Trading Statement)
Reporting Period: Third Quarter (Q3) ended 31 March 2025 and nine months ended 31 March 2025.
Date of Filing: 19 May 2025
Diageo reported strong organic net sales growth for Q3, driven by volume and price/mix, though partially offset by unfavorable foreign exchange and disposals. The company reiterated its full-year fiscal 25 guidance and launched the first phase of its "Accelerate" programme to improve operational agility and cost efficiency.
Key Financial Metrics
| Metric | Q3 Reported (F25) | Q3 Reported (F24) | Q3 Reported Growth | Q3 Organic Growth |
|---|---|---|---|---|
| Net Sales ($m) | 4,376 | 4,253 | 2.9% | 5.9% |
| Organic Volume | - | - | - | 2.8% |
| Price/Mix | - | - | - | 3.1% |
Nine Months to 31 March 2025: Reported net sales were $15,277m (0.4% growth), with organic net sales growth of 2.4% and organic volume growth of 0.6%.
Regional Performance (Q3 Organic Growth):
- North America: 6.2% (Driven by US Spirits shipment growth and tequila restocking).
- Latin America & Caribbean: 28.5% (Benefited from lapping prior year destocking).
- Africa: 10.1% (Strong growth in East and SWC Africa).
- Asia Pacific: 1.6% (Offset by downtrading and unfavorable mix).
- Europe: -0.4% (Guinness momentum offset by spirits softness).
Capital & Liquidity:
- Capital Expenditure (F25): Expected towards the upper end of the $1.3–1.5bn range.
- Leverage (F25 End): Expected to be 3.3–3.5x (above the 2.5–3.0x target range).
- Free Cash Flow (F26+): Target of c.$3bn per annum from the Accelerate programme.
Material Changes vs. Prior Period
- Phasing Impact: Q3 organic growth included an estimated 4% benefit from favorable phasing (mainly North America and Latin America), which is expected to reverse in Q4.
- Tariff Exposure: Assuming a 10% tariff on UK/EU imports to the US, the unmitigated annualized impact is estimated at c.$150m. Diageo expects to mitigate approximately half of this impact on operating profit through existing actions.
- Portfolio Changes: Completed sales of Guinness Nigeria, Safari, Pampero, and Caciquerum. Announced a joint venture with Main Street Advisors regarding Ciroc and Lobos 1707.
- Accounting Change: Effective tax rate reporting will change for full-year F25 to exclude the share of after-tax results of associates and joint ventures from profit before tax.
Guidance, Outlook, and Risks
Full Year Fiscal 25 Outlook:
- Organic Net Sales: Guidance reiterated; expects sequential improvement in H2 compared to H1.
- Organic Operating Profit: Expects a slight decline in H2 compared to the prior year, broadly in line with H1, including tariff impacts.
- Tax Rate: Expected to be c.25% (before exceptional items) on the new reporting basis.
- Interest Rate: Effective interest rate expected to be slightly below F24's 4.3%.
Accelerate Programme:
- Launches a c.$500m cost savings programme over three years.
- Aims to return leverage to the 2.5–3.0x target range no later than fiscal 28.
- Focuses on operational excellence and reinvestment in growth.
Risks and Contingencies:
- Macroeconomic Pressure: Continued uncertainty impacting the timing and pace of recovery.
- Tariffs: Potential for additional tariff changes beyond the current 10% assumption.
- Foreign Exchange: Spot rates at 31 March 2025 imply a negative impact of c.$250m on net sales and c.$200m on operating profit for F25.
Investor Verification Checklist
- Phasing Reversal: Verify the magnitude of the Q4 unwind of the 4% phasing benefit in North America and Latin America.
- Tariff Mitigation: Confirm the specific operational actions taken to mitigate the estimated $150m annualized tariff impact.
- Cost Savings Execution: Monitor progress on the c.$500m cost savings programme under the Accelerate initiative.
- Leverage Trajectory: Track debt reduction efforts to ensure the return to the 2.5–3.0x leverage target by fiscal 28.
- Asia Pacific Mix: Assess the impact of continued consumer downtrading and market mix issues in the Asia Pacific region.